HUMAN INTERLEUKIN-2 BASE ANTITUMOR AGENT SHOWING LOCAL-RESORPTIVE EFFECT Russian patent published in 1998 - IPC

FIELD: medicine, oncology. SUBSTANCE: antitumor agent has interleukin-2 at concentration 1000-20000 IU/1 g carrier. Agent is made in the form for local cutaneous using. Agent can contain additionally α-2-interferon (10 000-20 000 IU/1 g carrier) or tumor necrosis alpha-factor (5 000-20 000 IU/1 g carrier). Agent can contain additionally and simultaneously 2 000-20 000 IU α-2-interferon and 5 000-20 000 IU tumor necrosis alpha-factor/1 g carrier. Agent exhibits high activity of an active component at low levels that does not show adverse toxic effects. EFFECT: enhanced effectiveness of an antitumor agent. 4 cl, 4 dwg, 2 tbl, 20 ex